Graph Theoretical Analysis, In Silico Modeling, Synthesis, Anti-Microbial and Anti-TB Evaluation of Novel Quinoxaline Derivatives

Abstract

Background We designed to synthesize a number of 2-(2-(substituted benzylidene) hydrazinyl)-N-(4-((3-(phenyl imino)-3,4-dihydro quinoxalin-2(1 H)-ylidene)amino) phenyl) acetamide S1-S13 with the hope to obtain more active and less toxic anti-microbial and anti-TB agents.

Methods A series of novel quinoxaline Schiff bases S1-S13 were synthesized from o-phenylenediamine and oxalic acid by a multistep synthesis. In present work, we are introducing graph theoretical analysis to identify drug target. In the connection of graph theoretical analysis, we utilised KEGG database and Cytoscape software. All the title compounds were evaluated for their in-vitro anti-microbial activity by using agar well diffusion method at three different concentration levels (50, 100 and 150 µg/ml). The MIC of the compounds was also determined by agar streak dilution method.

Results The identified study report through graph theoretical analysis were highlights that the key virulence factor for pathogenic mycobacteria is a eukaryotic-like serine/threonine protein kinase, termed PknG. All compounds were found to display significant activity against entire tested bacteria and fungi. In addition the synthesized scaffolds were screened for their in vitro antituberculosis (anti-TB) activity against Mycobacterium tuberculosis (Mtb) strain H₃₇Ra using standard drug Rifampicin.

Conclusion A number of analogs found markedly potent anti-microbial and anti-TB activity. The relationship between the functional group variation and the biological activity of the evaluated compounds were well discussed. The observed study report was showing that the compound S6 (4-nitro substitution) exhibited most potent effective anti-microbial and anti-TB activity out of various tested compounds.

Key words

Graph theoretical analysis - Quinoxaline - Schiff base - Anti-bacterial - Anti-fungal and Anti-tubercular

• References

• 1 Khan SA, Asiri AM, Sharma K. Synthesis of steroidal thiazolidinones as antibacterial agents based on the in vitro and quantum chemistry calculation. Med Chem Res 2013; 22: 1998-2004
• 2 Walsh C. Opinion--anti-infectives: Where will new antibiotics come from?. Nat rev Microbiol 2003; 1: 65
• 3 Grundmann H, Aires-de-Sousa M, Boyce J. et al. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. The Lancet 2006; 368: 874-885
• 4 Clemett D, Markham A. Linezolid. Drugs 2000; 59: 815-827
• 5 Shah P. The need for new therapeutic agents: What is in the pipeline?. Clin Microbiol infec 2005; 11 (s3): 36-42
• 6 Wilson P, Andrews J, Charlesworth R. et al. Linezolid resistance in clinical isolates of Staphylococcus aureus. J Antimicrobial Chem 2003; 51: 186-188
• 7 Singh DP, Deivedi SK, Hashim SR. et al. Synthesis and antimicrobial activity of some new quinoxaline derivatives. Pharmaceuticals 2010; 3: 2416-2425
• 8 Rai B. Synthesis, Characterization and Antimicrobial Screening of Cobalt (II), Nickel (II) and Copper (II) Complexes with Schiff Base Derived from 2-Aroyl Quinoxaline Semicarbazone. Asian J Chem 2010; 22: 2761
• 9 Mohan J. Heterocyclic systems containing bridgehead nitrogen atom: Synthesis and bioactivity of 3-(2-thienyl)-s-triazolo [3, 4-b][1, 3, 4] thiadiazole, 2-(2-thienyl) thiazolo [3, 2-b]-s-triazole and isomeric 3-(2-thienyl)-thiazolo [2, 3-c]-s-triazole. 2003
• 10 Rajurkar R, Agrawal V, Thonte S. et al. Heterocyclic chemistry of quinoxaline and potential activities of quinoxaline derivatives. A review. Pharmacophore 2010; 1: 65-76
• 11 da Silva CM, da Silva DL, Modolo LV. et al. Schiff bases: A short review of their antimicrobial activities. J Advanced res 2011; 2: 1-8
• 12 Abu Mohsen U, Yurttas L, Acar U. et al. Synthesis and biological evaluation of some new amide moiety bearing quinoxaline derivatives as antimicrobial agents. Drug Res (Stuttg) 2015; 65: 266-271
• 13 Elhelby AA, Ayyad RR, Zayed MF. Synthesis and biological evaluation of some novel quinoxaline derivatives as anticonvulsant agents. Arzneimittelforschung 2011; 61: 379-381
• 14 Sainz Y, Montoya ME, Martínez-Crespo FJ. et al. Antonio Monge. New Quinoxaline 1,4-di-N-oxides for treatment of tuberculosis. Arzneimittelforschung 1999; 49: 55-59
• 15 Yadav L, Singh S. Synthesis of antiviral acyclic C-nucleosides incorporating thiazolo-1, 3, 4-oxa (thia) diazole or thiazolo-1, 2, 4-triazole structure as a nucleobase. 2001;
• 16 Mishra P, Paneerselvam P, Jain S. A Few 2-methylquinazolin-4(3 H)-ones as antimicrobial agents. J Ind Chem Soc 1995; 72: 559-560
• 17 Panneerselvam T, Arumugam S, Ali MA. et al. Design, network analysis, in silico modeling and synthesis of benzimidazoles nanocomposites as anticancer agent. Chem Select 2017; 2: 2341-2347
• 18 Theivendren P, Subramanian A, Murugan I. et al. Graph theoretical analysis, insilico modeling, design, and synthesis of compounds containing benzimidazole skeleton as antidepressant agents. Chem biol drug design 2017; 89: 714-722
• 19 Scardoni G, Petterlini M, Laudanna C. Analyzing biological network parameters with CentiScaPe. Bioinformatics 2009; 25: 2857-2859
• 20 Panneerselvam T, Sivakumar V, Arumugam S. et al. Design, Network analysis and in silico modeling of biologically significant 4-(substituted benzyl)-2-amino-6-hydroxypyrimidine-5-carboxamide nanoparticles. Drug Res 2017; 67: 289-301
• 21 Panneerselvam P, Rather BA, Reddy DRS. et al. Synthesis and anti-microbial screening of some Schiff bases of 3-amino-6, 8-dibromo-2-phenylquinazolin-4 (3 H)-ones. Euro Jmed chem 2009; 44: 2328-2333
• 22 Rameshkumar N, Ashokkumar M, Subramanian EH. et al. Synthesis of 6-fluoro-1, 4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives as potential antimicrobial agents. Euro j med chem 2003; 38: 1001-1004
• 23 AL-Hazimi HM, Al-Alshaikh MA. Microwave assisted synthesis of substituted furan-2-carboxaldehydes and their reactions. J Saudi Chem Soc 2010; 14: 373-382
• 24 Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob agents chemother 1997; 41: 1004-1009